Diabetes care · 2026
Continuous Glucose Monitoring-Guided Insulin Optimization in Patients Receiving Nocturnal Parenteral Nutrition.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Kerlogot Laurianne, Rigalleau Vincent, Pellet Gauthier, Chevrier Constance, Baldé Coraline, Wilsius Eva, Pidoux Marion, Jeamart Marion, Poullenot Florian
Аннотация
OBJECTIVE: To evaluate whether a continuous glucose monitoring (CGM) system (CGMS)-guided insulin optimization can improve glucose control and nutritional status in insulin-treated patients receiving long-term nocturnal parenteral nutrition (PN).
RESEARCH DESIGN AND METHODS: In this prospective single-center study, 12 insulin-treated adults with chronic intestinal failure undergoing nocturnal cyclic PN underwent 30-day CGM assessment before and after a diabetologist-led optimization of insulin therapy.
RESULTS: Glucose profiles improved after the intervention: less time >250 mg/dL (27% to 17%; -139 ± 113 min/day; P = 0.02), more time in range (44% to 59%; +206 ± 118 min/day; P = 0.002), and without more hypoglycemia. HbA1c decreased by -0.7% (-8 mmol/mol; P = 0.04), and glycosuria resolved in all affected patients (P = 0.03). Body weight increased by +5 kg (interquartile range 4-7.75; P = 0.006), as did serum albumin (+8 g/L; P = 0.006). Malnutrition resolved among 8 of 11 participants (P < 0.05).
CONCLUSIONS: CGMS-guided insulin optimization was associated with improvements in glucose control and nutritional status.
RESEARCH DESIGN AND METHODS: In this prospective single-center study, 12 insulin-treated adults with chronic intestinal failure undergoing nocturnal cyclic PN underwent 30-day CGM assessment before and after a diabetologist-led optimization of insulin therapy.
RESULTS: Glucose profiles improved after the intervention: less time >250 mg/dL (27% to 17%; -139 ± 113 min/day; P = 0.02), more time in range (44% to 59%; +206 ± 118 min/day; P = 0.002), and without more hypoglycemia. HbA1c decreased by -0.7% (-8 mmol/mol; P = 0.04), and glycosuria resolved in all affected patients (P = 0.03). Body weight increased by +5 kg (interquartile range 4-7.75; P = 0.006), as did serum albumin (+8 g/L; P = 0.006). Malnutrition resolved among 8 of 11 participants (P < 0.05).
CONCLUSIONS: CGMS-guided insulin optimization was associated with improvements in glucose control and nutritional status.